表紙
市場調査レポート

細胞株作製市場:製品別(設備、培地、試薬)、ソース、種類、用途別(生物学的生産、ティッシュエンジニアリング、再生医療、毒性試験、研究、創薬)の分析と世界市場の予測

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application (Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

発行 MarketsandMarkets 商品コード 315174
出版日 ページ情報 英文 220 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
細胞株作製市場:製品別(設備、培地、試薬)、ソース、種類、用途別(生物学的生産、ティッシュエンジニアリング、再生医療、毒性試験、研究、創薬)の分析と世界市場の予測 Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application (Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
出版日: 2014年09月22日 ページ情報: 英文 220 Pages
概要

世界の細胞株作製市場は、モノクローナル抗体の需要拡大、ワクチンの増産、革新的技術の使用などによって成長が促されています。インドやアフリカなど、基本的医療へのアクセスが不足し、流行病や伝染病のリスクが高まる低所得の国々に市場の機会があります。

当レポートは、世界の細胞株作製市場について調査し、製品別、ソース別、種類別、用途別、および地域別の動向、市場に参入する主要企業のシェアとプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

  • 市場規模
  • 地域別、種類別市場
  • 地域別概要
  • 製品別市場シェア
  • 地域別ライフサイクル分析

第5章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 課題
    • 機会

第6章 業界動向

  • イントロダクション
  • 主要企業による競合ポジショニング
  • 成長戦略評価
  • 技術評価

第7章 製品別市場

  • イントロダクション
  • 設備別市場
    • イントロダクション
    • 生物安全性キャビネット
    • 細胞カウンター・生存応力分析システム
    • インキュベーター
    • 遠心分離機
    • バイオリアクター
    • 保管設備
    • 自動システム
    • 顕微鏡
    • ろ過システム
    • その他
  • 培地、試薬別市場
    • イントロダクション
    • 培地および試薬

第8章 ソース別市場

  • イントロサクション
  • 哺乳類
  • 昆虫
  • 両生類

第9章 種類別市場

  • イントロダクション
  • 一次細胞株
  • 継続細胞株
  • ハイブリドーマ
  • 組換え細胞株

第10章 用途別市場

  • イントロダクション
  • 生物学的生産
  • 組織エンジニアリング・再生医療
  • 毒性試験
  • 研究
  • 創薬

第11章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 競合動向
    • 協定、連携
    • 新製品上市
    • 拡大
    • 買収
    • その他

第13章 企業プロファイル

第14章 付録

図表

目次
Product Code: BT 2750

Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have led to growth in a number of applications of cell lines such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery.

Cell line development media and reagents account for the largest share in the global cell line development market, as they have numerous applications in areas such as bioproduction, tissue engineering and regenerative medicine, toxicity testing, research, and drug discovery. The reagents segment accounted for the maximum share of the cell line development media and reagents market. The bioproduction segment accounted for the largest share of the cell line development application market, as cell lines are extensively used in diagnostics, vaccine production, and in manufacturing of recombinant protein therapeutics.

North America accounted for the largest share of the global cell line development market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cell line development market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to serve as revenue pockets for cell line manufacturers.

The global cell line development market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographical expansions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the cell line development market. The report analyzes cell line development products by equipment and media and reagents
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the cell line development market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell line development technologies across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the cell line development market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products and services, distribution networks, and manufacturing capabilities of the leading players in the cell line development market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Markets Covered
  • 1.3. Stakeholders

2. Research Methodology

  • 2.1. Secondary and Primary Research Methodology
    • 2.1.1. Secondary Research
  • 2.2. Key Data From Secondary Sources
    • 2.2.1. Primary Research
  • 2.3. Key Data From Primary Sources
  • 2.4. Key Insights From Primary Sources
    • 2.4.1. Key Industry Insights 27
  • 2.5. Market Size Estimation Methodology
  • 2.6. Market Forecast Methodology
  • 2.7. Market Data Validation and Data Triangulation
  • 2.8. Assumptions
  • 2.9. Limitations

3. Executive Summary

4. Premium Insights

  • 4.1. Market Size
  • 4.2. Cell Line Development Market, By Geography and Type
  • 4.3. Geographical Snapshot
  • 4.4. Market Share, By Product
  • 4.5. Life Cycle Analysis, By Geography

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
      • 5.2.1.1. Global Increase in Demand for Monoclonal Antibodies
      • 5.2.1.2. Innovative Technologies Accelerating the Scale-Up of Cell Lines
      • 5.2.1.3. Rise in Vaccine Production
    • 5.2.2. Challenge
      • 5.2.2.1. Developing Stable and Authentic Cell Lines
    • 5.2.3. Opportunities
      • 5.2.3.1. Increasing Risk of Pandemics and Communicable Diseases
      • 5.2.3.2. Low Income Countries to Create Opportunities for the Cell Line Market

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Competitive Positioning, By Key Player (2014)
    • 6.2.1. Introduction
    • 6.2.2. Key Highlights
  • 6.3. Cell Line Development Market: Emperical Assessment of Growth Strategies
    • 6.3.1. Route to Growth Strategies: Organic and Inorganic Growth Strategies 50
    • 6.3.2inorganic Growth Strategies 51
    • 6.3.3organic Growth Strategies 52
  • 6.4. Technology Assessment
    • 6.4.1. Expression Systems
      • 6.4.1.1. Methotrexate Amplification (DHFR) Technology
      • 6.4.1.2. Glutamine Synthatase (GS) Technology
      • 6.4.1.3. Viral-Based Technology

7. Global Cell Line Development Market, By Product

  • 7.1. Introduction
  • 7.2. Cell Line Development Market, By Product
  • 7.3. Global Cell Line Development Market, By Equipment
    • 7.3.1. Introduction
    • 7.3.2. Biosafety Cabinets
    • 7.3.3. Cell Counters & Viability Analysis Systems
    • 7.3.4. Incubators
    • 7.3.5. Centrifuges
    • 7.3.6. Bioreactors
    • 7.3.7. Storage Equipment
      • 7.3.7.1. Refrigerators & Freezers
      • 7.3.7.2. Cryostorage Systems
    • 7.3.8. Automation Systems
    • 7.3.9. Microscopes
    • 7.3.10. Filtration Systems
    • 7.3.11. Other Equipment
  • 7.4. Global Cell Line Development Market, By Media & Reagents
    • 7.4.1. Introduction
    • 7.4.2. Cell Line Media & Reagents
      • 7.4.2.1. Sera
        • 7.4.2.1.1. Fetal Bovine Sera (FBS)
        • 7.4.2.1.2. Adult Bovine Sera (ABS)
        • 7.4.2.1.3. Other Animal Sera
      • 7.4.2.2. Media
        • 7.4.2.2.1. Minimum Essential Media (MEM)
        • 7.4.2.2.2. Reduced Serum Media
        • 7.4.2.2.3. Serum-Free Media (SFM)
      • 7.4.2.3. Reagents
        • 7.4.2.3.1. Supplements & Growth Factors
        • 7.4.2.3.2. Buffers & Chemicals
        • 7.4.2.3.3. Cell Dissociation Reagents
        • 7.4.2.3.4. Cryopreservative Reagents
        • 7.4.2.3.5. Other Reagents

8. Cell Line Development Market, By Source

  • 8.1introduction
  • 8.2. Mammalian
  • 8.3. Insect
  • 8.4. Amphibian

9. Cell Line Development Market, By Type

  • 9.1. Introduction
  • 9.2. Primary Cell Lines
  • 9.3. Continuous Cell Lines
  • 9.4. Hybridomas
  • 9.5. Recombinant Cell Lines

10. Global Cell Line Development Market, By Application

  • 10.1. Introduction
  • 10.2. Bioproduction
    • 10.2.1. Diagnostics
    • 10.2.2. Vaccine Production
    • 10.2.3. Recombinant Protein Therapeutics
  • 10.3. Tissue Engineering & Regenerative Medicine
  • 10.4. toxicity Testing
  • 10.5. Research
  • 10.6. Drug Discovery
    • 10.6.1. Target Validation
    • 10.6.2. Disease Modeling
    • 10.6.3. Drug Screening and Development

11. Cell Line Development Market, By Geography

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
      • 11.2.1.1. R&D Investments By Pharmaceutical Companies in the U.S. to Propel the Cell Line Development Market
      • 11.2.1.2. Rise in Funding for Vaccine Production Likely to Fuel Demand of Cell Line Market
      • 11.2.1.3. Conferences on Cell Line to Propel Growth of Market
    • 11.2.2. Canada
      • 11.2.2.1. Increasing Investments on Regenerative Medicines By Canadian Government to Spur the Market
  • 11.3. Europe
    • 11.3.1. Flourishing Vaccine Market in Europe-A Major Propellant for the Cell Line Development Market
    • 11.3.2. France
      • 11.3.2.1. Increasing Use of Cell Lines for Vaccine Production to Spur Market in France
    • 11.3.3. Germany
      • 11.3.3.1. Advances in Biotechnology Fueling the Cell Line Development Market in Germany
    • 11.3.4. U.K.
      • 11.3.4.1. Conferences on Cell Line to Spur Market in the U.K.
    • 11.3.5. Rest of Europe (ROE)
      • 11.3.5.1. Increasing Research on Regenerative Medicines in Spain to Propel the Cell Line Market
  • 11.4. Asia
    • 11.4.1. India
      • 11.4.1.1. Growing Pharmaceutical Industry to Propel the Market in India
    • 11.4.2. China
      • 11.4.2.1. Developing Pharmaceutical Industry to Spur the Market in China
    • 11.4.3. Japan
      • 11.4.3.1. Rise in Production of Vaccines in Japan to Propel the Use of Cell Lines
      • 11.4.3.2. Regenerative Medicine, Biomedical, and Medical Research in Japan is on the Rise
    • 11.4.4. Rest of Asia (Roa)
      • 11.4.4.1. Initiation of Measles-Rubella Combined Vaccine Production in Vietnam
      • 11.4.4.2. Government-Supported Strong Academic and Commercial R&D Activities in Taiwan
  • 11.5. Rest of the World (ROW)
    • 11.5.1. Pacific Countries
      • 11.5.1.1. Federal Collaborations in Australia to Bolster the Demand of Cell Lines
      • 11.5.1.2. Favorable Regulatory Changes to Drive the Market in New Zealand and Australia
    • 11.5.2. Brazil
      • 11.5.2.1. Flourishing Biotechnology and Pharmaceutical Markets in Brazil to Bolster the Cell Line Development Market
    • 11.5.3. Africa
      • 11.5.3.1. Increasing Focus on Africa By Pharmaceutical Companies Likely to Create Avenues for Cell Line Development Market

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Market Share Analysis, Cell Line Development Market
    • 12.2.1. Introduction
      • 12.2.1.1. American Type Culture Collection (ATCC) (U.S.)
      • 12.2.1.2. Lonza Group AG (Switzerland)
      • 12.2.1.3. Thermo Fisher Scientific, Inc. (U.S.)
  • 12.3. Competitive Situation and Trends
    • 12.3.1. Agreements, Partnerships, and Collaborations
    • 12.3.2. New Product Launches
    • 12.3.3. Expansions
    • 12.3.4. Acquisitions
    • 12.3.5. Others

13. Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 13.1. Introduction
  • 13.2. American Type Culture Collection (ATCC)
  • 13.3. Corning, Inc.
  • 13.4. European Collection of Cell Cultures (ECACC)
  • 13.5. Ge Healthcare
  • 13.6. Lonza Group AG
  • 13.7. Sartorius AG
  • 13.8. Selexis SA
  • 13.9. Sigma-Aldrich Corporation
  • 13.10. Thermo Fisher Scientific, Inc.
  • 13.11. Wuxi Apptec

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. Introducing RT: Real Time Market Intelligence
  • 14.3. Available Customizations
  • 14.4. Related Reports

List of Tables

  • Table 1: Drivers Propelling the Growth of Cell Line Development Market
  • Table 2: Challenge of Cell Line Development Market
  • Table 3: Opportunies for Cell Line Development Market
  • Table 4: Market Size, By Product, 2012-2019 ($Million)
  • Table 5: Market Size for Equipment, By Region, 2012-2019 ($Million)
  • Table 6: Market Size, By Equipment, 2012-2019 ($Million)
  • Table 7: Market Size for Biosafety Cabinets, By Region,2012-2019 ($Million)
  • Table 8: Market Size for Cell Counters & Viability Analysis Systems, By Region, 2012-2019 ($Million)
  • Table 9: Market Size for Incubators, By Region, 2012-2019 ($Million)
  • Table 10: Market Size for Centrifuges, By Region, 2012-2019 ($Million)
  • Table 11: Market Size for Bioreactors, By Region, 2012-2019 ($Million)
  • Table 12: Market Size for Storage Equipment,By Region,2012-2019 ($Million)
  • Table 13: Market Size for Storage Equipment, By Segment,2012-2019 ($Million)
  • Table 14: Market Size for Refrigerators & Freezers, By Region, 2012-2019 ($Million)
  • Table 15: Market Size for Cryostorage Systems, By Region, 2012-2019 ($Million)
  • Table 16: Market Size for Automation Systems, By Region,2012-2019 ($Million)
  • Table 17: Market Size for Microscopes, By Region, 2012-2019 ($Million)
  • Table 18: Market Size for Filtration Systems, By Region,2012-2019 ($Million)
  • Table 19: Market Size for Other Equipment, By Region,2012-2019 ($Million)
  • Table 20: Market Size for Media & Reagents, By Segment,2012-2019 ($Million)
  • Table 21: Market Size for Media & Reagents, By Region,2012-2019 ($Million)
  • Table 22: Market Size for Sera, By Region, 2012-2019 ($Million)
  • Table 23: Market Size for Sera, By Segment, 2012-2019 ($Million)
  • Table 24: Market Size for Fetal Bovine Sera, By Region,2012-2019 ($Million)
  • Table 25: Market Size for Adult Bovine Sera, By Region,2012-2019 ($Million)
  • Table 26: Market Size for Other Animal Sera, By Region,2012-2019 ($Million)
  • Table 27: Market Size for Media, By Region, 2012-2019 ($Million)
  • Table 28: Market Size for Media, By Segment, 2012-2019 ($Million)
  • Table 29: Market Size for Minimum Essential Media, By Region, 2012-2019 ($Million)
  • Table 30: Market Size for Reduced Serum Media, By Region, 2012-2019 ($Million)
  • Table 31: Market Size for Serum-Free Media, By Region,2012-2019 ($Million)
  • Table 32: Market Size for Reagents, By Region, 2012-2019 ($Million)
  • Table 33: Market Size for Reagents, By Segment, 2012-2019 ($Million)
  • Table 34: Market Size for Supplements & Growth Factors,By Region, 2012-2019 ($Million)
  • Table 35: Market Size for Buffers & Chemicals, By Region,2012-2019 ($Million)
  • Table 36: Market Size for Cell Dissociation Reagents, By Region, 2012-2019 ($Million)
  • Table 37: Market Size for Cryopreservative Reagents, By Region, 2012-2019 ($Million)
  • Table 38: Market Size for Other Reagents, By Region,2012-2019 ($Million)
  • Table 39: Market Size, By Source, 2012-2019 ($Million)
  • Table 40: Types of Mammalian Cell Lines and Their Applications
  • Table 41: Market Size for Mammalian Sources, By Region,2012-2019 ($Million)
  • Table 42: Market Size for Insect Sources, By Region,2012-2019 ($Million)
  • Table 43: Market Size for Amphibian Sources, By Region,2012-2019 ($Million)
  • Table 44: Market Size, By Type, 2012-2019 ($Million)
  • Table 45: Market Size for Primary Cell Lines, By Region,2012-2019 ($Million)
  • Table 46: Market Size for Continuous Cell Lines, By Region, 2012-2019 ($Million)
  • Table 47: Market Size for Hybridomas, By Region, 2012-2019 ($Million)
  • Table 48: Biologics Produced Using Cho Cells (2006-2012)
  • Table 49: Market Size for Recombinant Cell Lines, By Region,2012-2019 ($Million)
  • Table 50: Cell Line Development Applications Market Size, By Region, 2012-2019 ($Million)
  • Table 51: Market Size, By Application, 2012-2019 ($Million)
  • Table 52: Market Size for Bioproduction, By Region,2012-2019 ($Million)
  • Table 53: Market Size for Bioproduction, By Segment,2012-2019 ($Million)
  • Table 54: Market Size for Diagnostics, By Region, 2012-2019 ($Million)
  • Table 55: Market Size for Vaccine Production, By Region,2012-2019 ($Million)
  • Table 56: Market Size for Recombinant Protein Therapeutics,By Region, 2012-2019 ($Million)
  • Table 57: Market Size for Tissue Engineering & Regenerative Medicine, By Region, 2012-2019 ($Million)
  • Table 58: Cell Line Development Market Size for toxicity Testing, By Region,2012-2019 ($Million)
  • Table 59: Market Size for Research Applications, By Region, 2012-2019 ($Million)
  • Table 60: Market Size for Drug Discovery, By Region,2012-2019 ($Million)
  • Table 61: Cell Line Development Market Size, By Region, 2012-2019 ($Million)
  • Table 62: North America: Cell Line Development Market Size, By Product, 2012-2019 ($Million)
  • Table 63: North America: Equipment Market Size, 2012-2019 ($Million)
  • Table 64: North America: Media & Reagents Market Size, 2012-2019 ($Million)
  • Table 65: North America: Market Size, By Source, 2012-2019 ($Million)
  • Table 66: North America: Market Size, By Type, 2012-2019 ($Million)
  • Table 67: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 68: U.S.: Market Size, By Product, 2012-2019 ($Million)
  • Table 69: U.S.: Market Size, By Source, 2012-2019 ($Million)
  • Table 70: U.S.: Market Size, By Type, 2012-2019 ($Million)
  • Table 71: U.S.: Market Size, By Application, 2012-2019 ($Million)
  • Table 72: Canada: Market Size, By Product, 2012-2019 ($Million)
  • Table 73: Canada: Market Size, By Source, 2012-2019 ($Million)
  • Table 74: Canada: Market Size, By Type, 2012-2019 ($Million)
  • Table 75: Canada: Market Size, By Application, 2012-2019 ($Million)
  • Table 76: Europe: Cell Line Development Market Size, By Product, 2012-2019 ($Million)
  • Table 77: Europe: Cell Line Development Equipment Market Size, 2012-2019 ($Million)
  • Table 78: Europe: Cell Line Development Media & Reagents Market Size, 2012-2019 ($Million)
  • Table 79: Europe: Market Size, By Source, 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By Type, 2012-2019 ($Million)
  • Table 81: Europe: Market Size, By Application, 2012-2019 ($Million)
  • Table 82: France: Market Size, By Product, 2012-2019 ($Million)
  • Table 83: France: Market Size, By Source, 2012-2019 ($Million)
  • Table 84: France: Market Size, By Type, 2012-2019 ($Million)
  • Table 85: France: Market Size, By Application, 2012-2019 ($Million)
  • Table 86: Germany: Market Size, By Product, 2012-2019 ($Million)
  • Table 87: Germany: Market Size, By Source, 2012-2019 ($Million)
  • Table 88: Germany: Market Size, By Type, 2012-2019 ($Million)
  • Table 89: Germany: Market Size, By Application, 2012-2019 ($Million)
  • Table 90: U.K.: Market Size, By Product, 2012-2019 ($Million)
  • Table 91: U.K.: Market Size, By Source, 2012-2019 ($Million)
  • Table 92: U.K.: Market Size, By Type, 2012-2019 ($Million)
  • Table 93: U.K.: Market Size, By Application, 2012-2019 ($Million)
  • Table 94: ROE: Market Size, By Product, 2012-2019 ($Million)
  • Table 95: ROE: Market Size, By Source, 2012-2019 ($Million)
  • Table 96: ROE: Market Size, By Type, 2012-2019 ($Million)
  • Table 97: ROE: Market Size, By Application, 2012-2019 ($Million)
  • Table 98: Asia: Market Size, By Product, 2012-2019 ($Million)
  • Table 99: Asia: Cell Line Development Equipment Market Size, 2012-2019 ($Million)
  • Table 100: Asia: Media & Reagents Market Size, 2012-2019 ($Million)
  • Table 101: Asia: Market Size, By Source, 2012-2019 ($Million)
  • Table 102: Asia: Market Size, By Type, 2012-2019 ($Million)
  • Table 103: Asia: Market Size, By Application, 2012-2019 ($Million)
  • Table 104: ROW: Cell Line Development Market Size, By Product, 2012-2019 ($Million)
  • Table 105: ROW: Cell Line Development Equipment Market Size, 2012-2019 ($Million)
  • Table 106: ROW: Cell Line Development Media & Reagents Market Size, 2012-2019 ($Million)
  • Table 107: ROW: Market Size, By Source, 2012-2019 ($Million)
  • Table 108: ROW: Market Size, By Type, 2012-2019 ($Million)
  • Table 109: ROW: Market Size, By Application, 2012-2019 ($Million)
  • Table 110: Agreements, Partnerships, and Collaborations 2011-2014
  • Table 111: New Product Launches, 2011-2013
  • Table 112: Expansions, 2011-2014
  • Table 113: Acquisitions, 2011-2014
  • Table 114: Others, 2011-2014

List of Figures

  • Figure 1: Market Segmentation
  • Figure 2: Research Methodology Steps
  • Figure 3: Sampling Frame: Primary Research
  • Figure 4: Break Down of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 6: Market Size Estimation Methodology: Top-Down Approach
  • Figure 7: Market forecast Methodology
  • Figure 8: Data Triangulation Methodology
  • Figure 9: Market Snapshot, By Product, 2014-2019 32
  • Figure 10: Media and Reagents Market To Witness Highest CAGR of 13% From 2014 To 2019 33
  • Figure 11: Market Share, 2014
  • Figure 12: Market Overview
  • Figure 13: North America Accounts for Largest Share of Market; Recombinant Cell Lines Accounts for 70% of Market, By Type
  • Figure 14: Asian Cell Line Market To Grow At the Highest CAGR Between 2014 and 2019
  • Figure 15: Media and Reagents To Command Over 50% of the Market Share, 2014 Vs. 2019 38
  • Figure 16: ROW is Expected To Enter the Exponential Growth Phase in the Coming Years
  • Figure 17: increasing Demand for Monoclonal Antibodies To Spur the Demand for This Market
  • Figure 18: Competitive Positioning, By Key Player (2014)
  • Figure 19: Competitive Positioning, By Key Player (2014)
  • Figure 20: Evolution of Cell Line Development Technologies
  • Figure 21: Comparative Technology Assessment - Cell Line Market
  • Figure 22: The Media & Reagents Segment is Expected To Grow At A Faster Pace Than the Equipment Segment From 2014 To 2019
  • Figure 23: Asia is Expected To Be the Fastest-Growing Cell Line Market At A CAGR of 14.8% From 2014 To 2019
  • Figure 24: North America is Expected To Account for the Largest Share of the Cell Line Equipment Market in 2014
  • Figure 25: The Other Equipment Segment is Expected To Command the Largest Share of the Cell Line Equipment Market in 2014
  • Figure 26: Refrigerators & Freezers Segment is Expected To Account for the Largest Share of 70% of the Cell Line Market for Storage Equipment in 2014
  • Figure 27: The Reagents Segment is Expected To Dominate the Cell Line Market
  • Figure 28: Asia is the Fastest-Growing Regional Segment of the Cell Line Market for Media & Reagents
  • Figure 29: Cell Line Market for Sera, By Segment
  • Figure 30: The Fetal Bovine Sera Segment is Expected To Command 60% of the Cell Line Market, Growing At the Highest CAGR of 5.8%
  • Figure 31: Cell Line Market for Media, By Segment
  • Figure 32: Minimal Essential Media To Grow At A Higher Rate From 2014 To 2019
  • Figure 33: Cell Line Market for Reagents, By Segment
  • Figure 34: The Supplements & Growth Factors Segment is Expected To Account for More Than 54% of the Global Market, and is Growing At the Highest CAGR of 13.3%
  • Figure 35: Cell Line Market, By Source
  • Figure 36: Mammalian Segment is Poised To Double in Size By 2019
  • Figure 37: With Wide Application Areas, Mammalian Segment Holds 75% of the Market in 2014
  • Figure 38: Cell Line Market, By Type
  • Figure 39: Recombinant Cell Lines Segment Accounts for 70% of the Cell Line Market, By Type
  • Figure 40: Hybridomas is the Fastest-Growing Segment of the Cell Line Market, By Type
  • Figure 41: Cell Line Applications Market, 2014-2019
  • Figure 42: Asia is the Fastest-Growing Region in the Global Cell Line Applications Market
  • Figure 43: Cell Line Development Market, By Application
  • Figure 44: Recombinant Protein therapeutics is Expected To Account for the Largest Share of 60% and is Growing At the Highest CAGR of 13.5%
  • Figure 45: North America is Expected To Command of the Largest Share of Global Cell Line Market in 2014
  • Figure 46: North America Accounted for Largest Share of 40% of the Market in 2014
  • Figure 47: European Cell Line Market Estimated To Grow At A Gagr of 11% From 2014 To 2019)
  • Figure 48: Asia is the Fastest Growing Cell Line Market With A CAGR of 14.8% From 2014 To 2019
  • Figure 49: ROW To Grow At A CAGR of 11.3% From 2014 To 2019
  • Figure 50: Companies Adopted Agreements, Partnerships, and Collaborations As the Key Growth Strategy Over the Last Three Years
  • Figure 51: Market Share Analysis, By Key Player, 2013
  • Figure 52: Key Growth Strategies of the Global Market, 2011-2014
  • Figure 53: Battle for Market Share: Agreements, Partnerships, and Collaborations Was the Key Strategy
  • Figure 54: Geographical Revenue Mix of Top 5 Market Players
  • Figure 55: Company Snapshot
  • Figure 56: Company Snapshot
  • Figure 57: Company Snapshot
  • Figure 58: Company Snapshot
  • Figure 59: Company Snapshot
  • Figure 60: Company Snapshot
  • Figure 61: Company Snapshot
  • Figure 62: Company Snapshot
  • Figure 63: Company Snapshot
  • Figure 64: Company Snapshot
Back to Top